Statement on FDA’s Final Guidance Delay for Lab-Developed Tests

Senate health committee Chairman Lamar Alexander weighs in on FDA pushing final guidance to next administration.

Chairman Alexander / Photo: Getty Images
Chairman Alexander / Photo: Getty Images

On November 18th, Lamar Alexander, Chairman of the Senate health committee, gave a statement regarding the FDA’s decision to delay making final guidance on lab-developed tests:

“I am glad that the FDA has listened and will delay making final its current draft guidance that could have halted more than 60,000 lab-developed tests in their tracks, and will work with Congress and the new administration on next steps. These tests are essential to helping millions of Americans screen for and diagnose diseases and conditions and advancing the president’s Precision Medicine Initiative to find more tailored treatments and cures. It is important to get this right.”

Click here to see this and other statements from Chairman Alexander.

More in Regulatory